GR3002832T3 - Flavone carboxylic acid derivatives - Google Patents

Flavone carboxylic acid derivatives

Info

Publication number
GR3002832T3
GR3002832T3 GR91401422T GR910401422T GR3002832T3 GR 3002832 T3 GR3002832 T3 GR 3002832T3 GR 91401422 T GR91401422 T GR 91401422T GR 910401422 T GR910401422 T GR 910401422T GR 3002832 T3 GR3002832 T3 GR 3002832T3
Authority
GR
Greece
Prior art keywords
carboxylic acid
iii
chem
formula
represents hydrogen
Prior art date
Application number
GR91401422T
Other languages
Greek (el)
English (en)
Inventor
Koichi Prof Shudo
Original Assignee
Shudo Koichi
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shudo Koichi, Shionogi & Co filed Critical Shudo Koichi
Publication of GR3002832T3 publication Critical patent/GR3002832T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
GR91401422T 1986-03-18 1991-10-03 Flavone carboxylic acid derivatives GR3002832T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61059850A JPS62215581A (ja) 1986-03-18 1986-03-18 フラボンカルボン酸誘導体

Publications (1)

Publication Number Publication Date
GR3002832T3 true GR3002832T3 (en) 1993-01-25

Family

ID=13125083

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91401422T GR3002832T3 (en) 1986-03-18 1991-10-03 Flavone carboxylic acid derivatives

Country Status (7)

Country Link
US (2) US4831052A (enExample)
EP (1) EP0237986B1 (enExample)
JP (1) JPS62215581A (enExample)
AT (1) ATE67995T1 (enExample)
DE (1) DE3773415D1 (enExample)
ES (1) ES2040217T3 (enExample)
GR (1) GR3002832T3 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0374789A1 (en) * 1988-12-19 1990-06-27 Kyowa Hakko Kogyo Co., Ltd. 5- Aminoflavone derivatives
US5194664A (en) * 1989-02-10 1993-03-16 Basf Aktiengesellschaft Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
DE3903992A1 (de) * 1989-02-10 1990-08-16 Basf Ag Aromatische ketoverbindungen, ihre herstellung und arzneimittel sowie kosmetika daraus
FR2661410B1 (fr) * 1990-04-27 1994-06-03 Caignard Daniel Nouveaux derives heterocycliques: 2-styryl 4h-1-benzopyrane-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE617614T1 (de) * 1991-12-18 1995-06-08 Baylor College Of Medicine, Houston, Tex. Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen.
EP0619116A3 (en) * 1993-04-05 1994-11-23 Hoechst Japan Use of synthetic retinoids for osteopathy.
US5770383A (en) * 1994-12-30 1998-06-23 Ligand Pharmaceuticals, Inc. Tricyclic retinoids, methods for their production and use
US5770378A (en) * 1994-12-30 1998-06-23 Ligand Pharmaceuticals, Inc. Tricyclic retinoids, methods for their production and use
US5770382A (en) * 1994-12-30 1998-06-23 Ligand Pharmaceuticals, Inc. Tricyclic retinoids, methods for their production and use
AU726450B2 (en) 1995-10-06 2000-11-09 Ligand Pharmaceuticals Incorporated Dimer-selective RXR modulators and methods for their use
CA2334545A1 (en) * 1998-06-12 1999-12-16 Ligand Pharmaceuticals Incorporated Treatment of anti-estrogen resistant breast cancer using rxr modulators
DE19918365A1 (de) * 1999-04-22 2000-10-26 Stefan Martens Genetische Sequenz, die für Flavonsynthase II Enzyme kodiert, und deren Verwendung
EP1212322A2 (en) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
MXPA02002032A (es) * 1999-08-27 2003-05-19 Ligand Pharm Inc Compuestos moduladores del receptor de androgeno y metodos.
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
US6593493B1 (en) 1999-09-14 2003-07-15 Ligand Pharmaceuticals, Inc. RXR modulators with improved pharmacologic profile
FR2815033B1 (fr) 2000-10-06 2003-09-05 Negma Lab Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique
US9050310B2 (en) * 2004-06-25 2015-06-09 Minas Theodore Coroneo Treatment of ocular lesions
US20060204474A1 (en) * 2005-02-25 2006-09-14 Coroneo Minas T Treatment of epithelial layer lesions
GB0915196D0 (en) 2009-09-01 2009-10-07 King S College London Therapeutic compounds and their use
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042192A (en) * 1962-07-10 1966-09-14 Benger Lab Ltd Furochromone compounds
GB1461777A (en) * 1973-06-08 1977-01-19 Fisons Ltd 2-phenyl-4-oxo-4h-1-benzopyran derivatives
LU69423A1 (enExample) * 1974-02-19 1975-12-09
FR2516922A1 (fr) * 1981-11-25 1983-05-27 Lipha Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant
FR2543140B1 (fr) * 1983-03-24 1985-06-21 Cortial Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
JPS6122046A (ja) * 1984-07-07 1986-01-30 Koichi Shiyudo スチルベン誘導体
EP0170105B1 (en) * 1984-07-07 1990-10-17 Koichi Prof. Dr. Shudo Benzoic acid derivatives

Also Published As

Publication number Publication date
ATE67995T1 (de) 1991-10-15
DE3773415D1 (de) 1991-11-07
US4831052A (en) 1989-05-16
ES2040217T3 (es) 1993-10-16
JPS62215581A (ja) 1987-09-22
EP0237986B1 (en) 1991-10-02
EP0237986A2 (en) 1987-09-23
US4925979A (en) 1990-05-15
EP0237986A3 (en) 1988-10-05
JPH0255430B2 (enExample) 1990-11-27

Similar Documents

Publication Publication Date Title
EP0237986A3 (en) Flavone carboxylic acid derivatives
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
ES2057016T3 (es) Compuestos de acido 3-pirrolidiniltio-1-azabiciclo (3.2.0) hept-2-eno-2-carboxilico.
ATE107306T1 (de) 3-pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en- 2-carbonsäure-verbindungen.
FI894045A0 (fi) Menetelmä terapeuttisesti aktiivisen 10-atsaspiro-9-fluori-2,3-dihydro-3-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojohdannaisen valmistamiseksi
IE811250L (en) Imidazole derivatives
NZ196284A (en) 1-piperazino-3-phenylindane derivatives:pharmaceutical compositions
HU9300110D0 (en) Method for producing aryl-cycloalkyl derivatives and medical preparatives containing them as active substance
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
CA2103590A1 (en) Benzamide derivative
ES2090083T3 (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion antimicrobiana que contiene estos derivados.
EP0497001A3 (en) Oxidized-type glutathione alkyl ester
ATE89739T1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
HU9300202D0 (en) Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them
EP0123962A3 (en) Novel benzimidazole derivative, process for the preparation thereof and pharmaceutical composition
ES8500269A1 (es) Procedimiento para la fabricacion de un derivado de azolcarboxamida n,n-subsitutida.
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
PT1172108E (pt) Utilizacao de derivados de sulfoquinovosildiacilglicerol como imunossupressores
IE40727L (en) Aralkylamines
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
HUT60261A (en) Process for producing piperazine derivatives and pharmaceutical compositions comprising same
GB2007210A (en) Benzimidazole Derivatives
DE3173404D1 (en) Biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
MY105537A (en) Preparation process of new thieno-triazolo- diazepine.
CA2021881A1 (en) Process for preparing lankacidine carbamate derivatives